ATE205856T1 - Mit multiple-sklerose assoziierter, zytotoxischer faktor, seine detektion und quantifizierung - Google Patents

Mit multiple-sklerose assoziierter, zytotoxischer faktor, seine detektion und quantifizierung

Info

Publication number
ATE205856T1
ATE205856T1 AT95420031T AT95420031T ATE205856T1 AT E205856 T1 ATE205856 T1 AT E205856T1 AT 95420031 T AT95420031 T AT 95420031T AT 95420031 T AT95420031 T AT 95420031T AT E205856 T1 ATE205856 T1 AT E205856T1
Authority
AT
Austria
Prior art keywords
quantification
detection
multiple sclerosis
factor associated
cytotoxic factor
Prior art date
Application number
AT95420031T
Other languages
English (en)
Inventor
Herve Perron
Tomas Dobransky
Francois Rieger
Bernard Mandrand
Original Assignee
Bio Merieux
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Merieux filed Critical Bio Merieux
Application granted granted Critical
Publication of ATE205856T1 publication Critical patent/ATE205856T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/16—Dendrimers and dendritic polymers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/964—Chemistry: molecular biology and microbiology including enzyme-ligand conjugate production, e.g. reducing rate of nonproductive linkage
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/827—Lectins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/828—Protein A

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Physiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT95420031T 1994-02-15 1995-02-15 Mit multiple-sklerose assoziierter, zytotoxischer faktor, seine detektion und quantifizierung ATE205856T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9401946A FR2716198B1 (fr) 1994-02-15 1994-02-15 Facteur cytotoxique tel qu'associé à la sclérose en plaques, sa détection et sa quantification.

Publications (1)

Publication Number Publication Date
ATE205856T1 true ATE205856T1 (de) 2001-10-15

Family

ID=9460272

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95420031T ATE205856T1 (de) 1994-02-15 1995-02-15 Mit multiple-sklerose assoziierter, zytotoxischer faktor, seine detektion und quantifizierung

Country Status (13)

Country Link
US (2) US5876954A (de)
EP (1) EP0667354B1 (de)
JP (1) JP2803910B2 (de)
AT (1) ATE205856T1 (de)
AU (1) AU701972B2 (de)
CA (1) CA2142557C (de)
DE (1) DE69522725T2 (de)
DK (1) DK0667354T3 (de)
FI (1) FI954876L (de)
FR (1) FR2716198B1 (de)
NO (1) NO954081L (de)
NZ (1) NZ281260A (de)
WO (1) WO1995021859A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ279855A (en) 1994-02-04 1998-05-27 Bio Merieux Msrv1 and msrv2 pathogenic and/or infectious agents associated with ms, nucleic acids encoding them and diagnostic and therapeutic applications
US6284236B1 (en) 1995-06-29 2001-09-04 Immunex Corporation Cytokine that induces apoptosis
FR2745974B1 (fr) * 1996-03-14 1998-04-17 Animal modifie, utilisations et procede pour mesurer l'efficacite d'un procede therapeutique
EP0925504B1 (de) * 1996-09-12 2001-03-14 Bio Merieux Verfahren zur detektion und/oder quantitativen bestimmung von einem gliotoxischen faktor
WO1998023755A1 (en) * 1996-11-26 1998-06-04 Bio Merieux Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes
FR2765588A1 (fr) 1997-07-07 1999-01-08 Bio Merieux Materiel nucleique retroviral et fragments nucleotidiques notamment associes a la sclerose en plaques et/ou la polyarthrite rhumatoide, a des fins de diagnostic, prophylactiques et therapeutiques
FR2797402B1 (fr) * 1999-07-15 2004-03-12 Biomerieux Stelhys Utilisation d'un polypeptide pour detecter, prevenir ou traiter un etat pathologique associe a une maladie degenerative, neurologique ou autoimmune

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4346074A (en) * 1978-08-24 1982-08-24 National Research Development Corp. Pasteurellosis vaccines
US4311686A (en) * 1979-04-30 1982-01-19 The Immunology Development Corporation Methodology for the immunodiagnosis of multiple sclerosis and/or malignant diseases from blood sample analysis
US4396600A (en) * 1980-12-18 1983-08-02 Gus Gallucci Adult schistosome worm-derived antigenic substance and method of obtaining same
US4388298A (en) * 1982-07-14 1983-06-14 The United States Of America As Represented By The Secretary Of Agriculture Propagation of hemorrhagic enteritis virus in a turkey cell line and vaccine produced
GB8324800D0 (en) * 1983-09-15 1983-10-19 Pasteur Institut Antigens
US4520113A (en) * 1984-04-23 1985-05-28 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Serological detection of antibodies to HTLV-III in sera of patients with AIDS and pre-AIDS conditions
US4647773A (en) * 1984-04-23 1987-03-03 The United States Of America As Represented By The Department Of Health And Human Services Method of continuous production of retroviruses (HTLV-III) from patients with AIDS and pre-AIDS
NZ218050A (en) * 1985-11-13 1989-05-29 Wistar Inst Test for the presence of htlv-1v
US4900553A (en) * 1987-09-11 1990-02-13 Case Western Reserve University Method of reducing glial scar formation and promoting axon and blood vessel growth and/or regeneration through the use of activated immature astrocytes
EP0326395A2 (de) * 1988-01-29 1989-08-02 City Of Hope Verfahren zum Nachweis und zur Identifizierung von bestimmten viralen Sequenzien
FR2651581B1 (fr) * 1989-09-06 1994-05-13 Centre Nal Recherc Scientifique Moyens pour le diagnostic de neuropathies demyelinisantes, en particulier de la sclerose en plaques.
US5219837A (en) * 1990-06-21 1993-06-15 Trustees Of The University Of Pennsylvania Method of stimulating myelination of cells
US5158976A (en) * 1990-10-29 1992-10-27 The Children's Medical Center Corporation Controlling glutamine/glutamate related neuronal injury
DK173091D0 (da) * 1991-10-11 1991-10-11 Schleroseforeningen The Danish Biologisk materiale
FR2689520B1 (fr) * 1992-04-03 1996-07-19 Bio Merieux Procede et milieu de culture pour l'obtention de cellules infectees par un virus associe a la sclerose en plaques.
FR2689521B1 (fr) * 1992-04-03 1996-07-19 Bio Merieux Procede d'obtention et maintien d'une culture cellulaire viable, infectee par un virus associe a la sclerose en plaques, et produits biologiques derives de ladite culture.
WO1993023550A2 (en) * 1992-05-18 1993-11-25 Genentech, Inc. Activation of oligomerizing receptors by using fused receptor ligands
GB9310657D0 (en) * 1993-05-24 1993-07-07 Univ London Retrovirus

Also Published As

Publication number Publication date
EP0667354A1 (de) 1995-08-16
AU701972B2 (en) 1999-02-11
JP2803910B2 (ja) 1998-09-24
EP0667354B1 (de) 2001-09-19
FI954876A7 (fi) 1995-10-13
NO954081L (no) 1995-12-13
JPH08511808A (ja) 1996-12-10
DE69522725D1 (de) 2001-10-25
US5728540A (en) 1998-03-17
FR2716198B1 (fr) 1996-04-19
FI954876A0 (fi) 1995-10-13
US5876954A (en) 1999-03-02
NZ281260A (en) 1998-05-27
DK0667354T3 (da) 2002-01-14
FI954876L (fi) 1995-10-13
CA2142557A1 (fr) 1995-08-16
AU1815295A (en) 1995-08-29
DE69522725T2 (de) 2002-07-04
NO954081D0 (no) 1995-10-13
CA2142557C (fr) 2001-11-20
FR2716198A1 (fr) 1995-08-18
WO1995021859A1 (fr) 1995-08-17

Similar Documents

Publication Publication Date Title
DE69328528D1 (de) D-Ketohexose-3-Epimerase, und seine Herstellung und Verwendung
ATE150299T1 (de) Verwendung von derivaten des 4-phenyl-1,2,3,4- tetrahydro-1-naphthalenamins zur behandlung von psychose, entzündung und als immununterdrücker
DE69114327D1 (de) Toner und seine Herstellung.
DE69306402D1 (de) Niedrigschmelzendes tetrafluorethylene-copolymer und seine verwendung
IT1229195B (it) Derivati xantinici ad attivita' broncodilatatrice e loro applicazioni terapeutiche.
DE69228492D1 (de) 3,4,N-Trisubstituierte-4,5-dihydro-1H-Pyrazol-1-carboxamide und deren Anwendung als Insektizide
DK0543883T3 (da) Insektfordrivende middel
EP0581969A4 (de) Zinkoxidvaristor und seine herstellung.
DE58902181D1 (de) O-methylzimtsaeurephenylethylester, seine herstellung und verwendung als riechstoff.
ATE205856T1 (de) Mit multiple-sklerose assoziierter, zytotoxischer faktor, seine detektion und quantifizierung
DE69213362D1 (de) Elektrolyseur und Herstellung davon
FI981359A0 (fi) Uudet tiomarinolin johdannaiset ja menetelmät niiden valmistamiseksi
DE69109895D1 (de) Verwendung eines antibakteriellen und deodorierenden Agenz.
NO932502D0 (no) Nye fosfolipidderivater
DE69311463D1 (de) Pfropfpolymerteilchen, herstellung davon, und diese enthaltende zusammensetzung
FR2682457B1 (fr) Feu d'avertissement tournant, du type gyrophare.
DE69132635D1 (de) Picolinsäurederivat, seine herstellung und verwendung als herbizid
DE69016196D1 (de) Propanolderivate und diese enthaltende Duftstoffe.
ITMI911834A1 (it) Falciatrice o rispettivamente trinciapaglia
ES2039312T3 (es) Peptido bacteriocina.
DE69015602D1 (de) Oxadiazolinon-Derivat, seine Herstellung und seine Verwendung.
DE69129213D1 (de) Mittel zur Insektenabwehr
ATE126981T1 (de) Aufhängungshalterung und diese enthaltende aufhängungsanordnung.
FR2696643B1 (fr) Dispersat purifiant désinfectant odorisant.
DE3869232D1 (de) Abkoemmlinge von bornan-3-spiro-l'-cyclopentan und diese enthaltende riechstoffzusammensetzungen.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties